10x Genomics, Inc. (TXG) Balance Sheet

The equity expansion is driven by a combination of modest net losses offset by stock-based compensation and a reduction in total debt from $92.2M to $78.8M over the same period. This indicates that while operational performance is weak, the company is not eroding its balance sheet, but rather preserving capital. The trend suggests a defensive posture, with management prioritizing liquidity over growth, which may signal a cautious outlook.

The absolute debt level is modest relative to the $1.0B asset base, and the current ratio of 5.69 provides ample coverage. The reduction in debt from $157.7M in 2025Q4 to $78.8M in 2026Q2 suggests a deliberate deleveraging, possibly using cash reserves. This low leverage implies that the company is not reliant on external financing for operations, but it also means the balance sheet is not being used to fuel growth, which aligns with the decelerating revenue trend.

The increase in cash as a percentage of total assets (now over 50%) suggests a business model that is becoming more asset-light, with minimal capital expenditure requirements. The decline in PPE may reflect reduced investment in manufacturing capacity, which could be a response to lower demand. Goodwill remains negligible at $6.9M, so there is little impairment risk from acquisitions, but the shrinking asset base could limit future operational flexibility.

The flat retained earnings indicate that net losses are being offset by non-cash charges, particularly stock-based compensation, which averaged $27.6M per quarter. This means that reported equity growth is partly artificial, as it is funded by dilution rather than operational profitability. Investors should monitor the dilution impact, as it may mask the true economic performance of the company.

The cash position alone covers over two years of operating losses at the current burn rate, even without considering future revenue. This strong liquidity suggests that the company is not at immediate risk of a cash crunch, but it also implies that management may be hoarding cash rather than investing in growth opportunities. The high current ratio indicates efficient working capital management, but it may also reflect a lack of attractive investment opportunities.

The growth in deferred revenue, though modest in absolute terms, indicates that customers are still committing to future purchases, which may provide a slight buffer against revenue volatility. However, the trend is not robust, and the absolute level is small relative to quarterly revenue, so it does not significantly derisk the top line. This suggests that the company's forward visibility is limited, and the revenue decline may persist.